Experiences with amantadine hydrochloride in Parkinson's disease
Griffiths, A.V.; Parker, W.N.; Palmer, R.M.
Practitioner 207(241): 679-680
1971
ISSN/ISBN: 0032-6518 PMID: 5134819 Document Number: 37151
Document emailed within 1 workday
Related Documents
Silver, D.E.; Sahs, A.L. 1971: Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease Transactions of the American Neurological Association 96: 307-308Gospavić, J.; Vidaković, Z. 1974: Effectiveness of a combination therapy in the Parkinson syndrome by amantadine hydrochloride and anticholinergic agents Srpski Arhiv Za Celokupno Lekarstvo 102(6): 447-457
Campbell, A.M.; Williams, M.J. 1972: Trial of amantadine in Parkinson's disease British Journal of Clinical Practice 26(1): 19-22
Pendefunda, G.; Pollingher, B.; Stefanache, F.; Gavril, A.; Oprisan, C.; Merling, M.; Nemteanu, E.; Ciunru, M.; Koropitzer, I. 1975: The treatment with L-dopa and amantadine in Parkinson's disease Therapia Hungarica 23(1): 12-16
Danielczyk, W. 1995: Twenty-five years of amantadine therapy in Parkinson's disease Journal of Neural Transmission. Supplementum 46: 399-405
Fasano, V.A.; Urciuoli, R.; Broggi, G. 1971: On the treatment of Parkinson's disease with intravenous administration of amantadine (77 cases) Minerva Medica 62(82): 3968-3970
Dzudza, M.; Dzudza, D. 1974: Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease Medicinski Arhiv 28(4): 407-415
Hatchuel, W.L. 1971: The effect of symmetrel (amantadine hydrochloride) on a case of athetosis South African Medical Journal 45(18): 499-500
Ambrosini, P.J.; Fried, J. 1984: Preliminary report: amantadine hydrochloride in childhood enuresis Journal of Clinical Psychopharmacology 4(4): 223-225
Ing, T.S.; Mahurkar, S.D.; Dunea, G.; Hayashi, J.A.; Klawans, H.L.; Markey, W.S. 1976: Removal of amantadine hydrochloride by dialysis in patients with renal insufficiency Canadian Medical Association Journal 115(6): 515
Merrick, E.M.; Schmitt, P.P. 1973: A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel) Current Therapeutic Research 15(8): 552-558
Bucke, B.; Distler, H.J.; Schoyerer, R.; Willner, W. 1983: Rhinitis therapy. Experiences with triprolidine hydrochloride/pseudoephedrin hydrochloride, a decongestive and antiallergic therapeutic agent Fortschritte der Medizin 101(11): 494-496
Tsuda, N.; Negoro, K.; Morimatsu, M. 1994: A case of multiple cerebral infarctions associated with hemichorea induced by amantadine hydrochloride Rinsho Shinkeigaku 34(4): 388-390
Ferraris, M. 1971: Psychological status of patients with Parkinsonism during treatment with amantadine hydrochloride and L-Dopa Minerva Medica 62(82): 3971-3973
Nakamura, H.; Uyama, H.; Enomoto, H.; Kishima, Y.; Yamamoto, M.; Yoshida, K.; Okuda, Y.; Hirotani, T.; Kuroda, T.; Ito, H.; Matsuda, M.; Terabayashi, M.; Noguchi, S. 2003: The combination therapy of interferon and amantadine hydrochloride for patients with chronic hepatitis C Hepato-Gastroenterology 50(49): 222-226
Campanella, G.; Zallone, E.; Buscaino, G.A. 1972: Amantadine in the treatment of Parkinson's syndrome: studied in 31 patients for 3 months Acta Neurologica 27(5): 491-500
Puca, F.M.; Bricolo, A.; Turella, G. 1972: Effects of L-dopa or amantadine treatment on the spindles of sleep in Parkinson's syndromes Revue Neurologique (Paris) 127(2): 313
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262